Freiburg - The number of patients with chronic kidney failure has increased dramatically worldwide in recent years. The reason for this is the increasing number of people with diabetes, one of the main causes of kidney damage. So far, however, diabetic kidney damage can neither be effectively prevented nor treated.
An international research consortium is now analyzing the development and treatment of diabetic kidney damage. It is also intended to identify ways of identifying high-risk patients at an early stage. The consortium of total of 28 partners is funded by the and industrial partners with total of around 30 million euros.
Deutsches Ärzteblatt print
The new research consortium called Biomarker Enterprise to Attack DKD (BEAt-DKD) combines basic and applied research and is supported by public-private partnership between the European Union and who finances.